Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Tardive Dyskinesia Age: Adults |
Dose: by mouth – 40 mg Frequency: once daily Duration: 1 week Note: Initial dose |
|
Indication: Tardive Dyskinesia Age: Adults |
Dose: by mouth – 80 mg Frequency: once daily Note: Recommended maintenance dose; continuation of 40 mg once daily may be considered for some patients |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: Child |
Dose: No approved pediatric dosage available Note: No approved pediatric dosage available |
Renal Dose
| Clinical Information | Administration Information |
|---|---|
|
Condition: Renal impairment Mild-to-moderate (Creatinine Clearance 30-90 mL/min) |
Dose: No dose adjustment required Note: No dose adjustment required |
|
Condition: Renal impairment Severe (Creatinine Clearance less than 30 mL/min) |
Dose: Use not recommended Note: Use not recommended |
Administration
- Take with or without food
- Take at same time each day
Side Effect
- Somnolence (10.9%)
- Anticholinergic effects (5.4%)
- Balance disorders/fall (4.1%)
- Headache (3.4%)
- Akathisia (2.7%)
- Vomiting (2.6%)
- Nausea (2.3%)
- Arthralgia (2.3%)
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
No interactions listed
|
-
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
No specific contraindications listed
|
Monitor for general drug reactions
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Details coming soon
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.